When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or only MSI-positive tumors, accuracy fell substantially, revealing that the ...
In financial markets, nothing sells like doom. But recent fears about the disruptive potential of artificial intelligence ...